Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Vanquis swings back to black, shares spark

(Sharecast News) - Shares in Vanquis Banking Group jumped on Wednesday, after the lender swung back into profit. The former Provident Financial, a specialist in mid-cost and near-prime finance, has been hit by a swathe of no-win, no-fee complaints related to its credit card division.

The costs of processing the claims, despite the "vast majority" not being upheld, saw the Bradford-based firm slump to a £34.8m loss last year.

But updating on trading on Wednesday, Vanquis said it had returned to profitability during the first quarter.

Gross customer interest-earning balances rose 1.8% in the three months to March end, to £2.3bn.

The net interest margin was 17.8%, down 1.1% annually but unchanged on the fourth quarter.

Ian McLaughlin, chief executive, said: "Vanquis' strategic delivery remains on track. The group returned to profitability and grew gross customer interest-earning balances, building on the momentum shown in the fourth quarter of 2024.

"Overall costs remained well-controlled and credit quality was robust, with our customers continuing to show financial resilience."

McLaughlin also welcome the Financial Ombudsman Service's revised fee structure, which came into effect on 1 April.

Its introduction had led to a reduction in unmerited referrals from claims management companies, he noted, with complaint costs remaining in line with expectations.

As at 1130 BST, shares in Vanquis had put on 9% at 76.34p.

Provident Financial was founded in 1880 as a doorstep lender, but faced a surge in complaints in recent years, hitting both profits and the share price.

The firm therefore opted to move away from sub-prime doorstep lending in 2023, changing its name to that of its credit card business to better reflect its mix of products.

Share this article

Related Sharecast Articles

Astrazeneca secures US approval for Truqap combo in PTEN‑deficient prostate cancer
(Sharecast News) - Drugmaker Astrazeneca said on Monday that its cancer drug Truqap, used with abiraterone and prednisone, has been approved in the US as the first targeted treatment for a form of advanced prostate cancer driven by a fault in the PTEN gene.
Big Yellow sells Harrow industrial estate for £38.4m
(Sharecast News) - Big Yellow said it has sold its industrial estate in Harrow, London, for £38.4m, subject to a £2m retention from the sale price, which will be released on the satisfaction of certain conditions.
Frasers launches £166m bid for Australia's Accent Group
(Sharecast News) - Frasers Group said it had launched a bid to buy Australian sports footwear retailer Accent Group for £166m.
Oakley Capital not planning to bid for Gamma Communications
(Sharecast News) - Oakley Capital said on Friday that it does not plan to make a takeover offer for Gamma Communications.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.